Stockreport

Genentech Provides Update on Phase III persevERA Study in ER-positive Advanced Breast Cancer

ROCHE HOLDING LTD S/ADR  (RHHBY) 
NASDAQ:AMEX Investor Relations: roche.com/investors.htm
PDF persevERA Breast Cancer study did not meet the primary objective of a statistically significant improvement in progression-free survival, but a numerical improvement was [Read more]